Drugs like Ozempic and Wegovy have had a meteoric rise in recent years, with benefits like weight loss and help with other health issues. But according to a recent study, those benefits fade within two years of patients stopping their treatment.
According to a study published in the BMJ, data from 9,341 obese or overweight patients treated in 37 studies with any of 18 different weight-loss drugs showed that they regained about one pound on average after stopping the drugs.
The same study said they were projected to return to their pre-treatment weight in about two years.
But weight was not the only thing that was projected to return after stopping the treatment. According to the same study, health risk factors like blood pressure and cholesterol levels, which saw benefits while taking the drugs, were projected to return to their old levels within 1.4 years.
GLP-1 medications tested as well
About half of the patients studied took newer GLP-1 drugs like semaglutide, sold as Ozempic and Wegovy, as well as tirzepatide, which is sold as Mounjaro and Zepbound. According to the study, the weight regain rate was faster for these drugs, with an average of 1.8 pounds per month.
“But because people on semaglutide or tirzepatide lose more weight in the first place, they all end up returning to baseline at approximately the same time,” study senior researcher Dimitrios Koutoukidis of Oxford University told Reuters.
Weight loss drugs have shown some success
Weight loss drugs like the ones tested in the study have shown large levels of success in the United States in recent years. Back in October 2025, a survey from the Gallup National Health and Well-Being Index showed that there were an estimated 7.6 million fewer obese people in the United States compared to 2022.
In 2022, the U.S. adult obesity rate was a record-high 39.9%, while in 2025, that rate gradually declined to 37%. While the obesity rate dropped, the usage of GLP-1 drugs like Ozempic and Wegovy doubled between 2025 and 2024, according to the same study.
Contributing: Nicole Fallert, USA TODAY; Reuters
Fernando Cervantes Jr. is a trending news reporter for USA TODAY. Reach him at [email protected] and follow him on X @fern_cerv_.
This article originally appeared on USA TODAY: Here's how fast you can gain weight after ending GLP-1, per study
LATEST POSTS
- 1
Space Condos to Lift Your Metropolitan Living - 215 Preposterous Cosplay Ensembles That Will Blow You Away
- 3Single women risk rape and exploitation in search for better life in Europe
- 4Scientists dove hundreds of feet into the ocean and found creatures no human has ever seen. Our trash beat us there
- 5Bennu asteroid samples provide clues about solar system origins and 'space gum'
- Artemis 2 moon astronauts will try to recreate Apollo 8's historic 'Earthrise' photo during April 6 flyby
- Gov’t approves millions for border cities in North under Hezbollah fire
- 5 Movies That Leaving an Imprint with Inventive Innovation
- Israel Police arrest twenty-one as anti-war protests grow despite broad support for Iran war
- RFK Jr. wants to scrutinize the vaccine schedule – but its safety record is already decades long
- 10 Energizing Vocations in the Innovation Business
- ONE returns to Red Sea with new service
- NASA wants to build a base on the Moon by the 2030s – how and why it plans to build up to a long-term lunar presence
- What to watch for as NASA’s historic Artemis II crew prepares to lift off toward the moon
